Arax Advisory Partners’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
RG
Arax Advisory Partners's RGNX Position: Q2 2026 in Review
Arax Advisory Partners increased its Regenxbio (RGNX) stake by 2,495% in Q2 2026, buying an estimated $154K and bringing the position to 19,256 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #2155.
Arax Advisory Partners first reported a position in RGNX in Q2 2024 and has held it in 8 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Arax Advisory Partners held 19,256 shares of Regenxbio worth $231K as of Q2 2026.
- Arax Advisory Partners bought 18,514 Regenxbio shares in Q2 2026, an estimated $154K.
- Regenxbio made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2155 holding.
- Arax Advisory Partners first reported a position in Regenxbio in Q2 2024 and has held it in 8 quarters since.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.